Reju Medical Tourism


chronic obstructive pulmonary disease

How Stem Cell Treatment Can Help
People with COPD

COPD, or chronic obstructive pulmonary disease, refers to a group of lung diseases characterized by airflow blockage and breathing-related problems. COPDs are caused by long-term exposure to irritants that damage your lungs and airways. As in the case of emphysema and chronic bronchitis—two of the most common COPDs—the culprit is usually a smoking habit.

Structural damage and chronic inflammation both contribute to the airway obstruction found in COPD. Over time, inhaled irritants can damage the components of the respiratory system; furthermore, they can also cause the airways to become inflamed and narrowed.

To date, COPD remains incurable. Fortunately, mesenchymal stem cells (MSCs) have the potential to address both factors that contribute to the disease.

Stem cells are unspecialized cells with the unique ability to become any type of cell in the body, in a process called ‘differentiation’. When supplied to a patient’s body, these cells migrate to dead or damaged tissue, where they orchestrate repair and regeneration. When provided to COPD patients, MSCs may be able to repair and regenerate damaged lung tissue; furthermore, MSCs have natural anti-inflammatory properties that can help alleviate the inflammation that exacerbates COPD. While stem cell treatment for COPD is still in the early stages of development, there is already promising research that suggests that stem cell therapy may help with the disease. In a report called ‘Autologous Stem Cell Therapy & its Effects on COPD’, researchers at the Lung Health Institute found that over 82% of patients that attempted stem cell treatment experienced noticeable improvements in quality of life. Many patients reported increased lung capacity and the recovery of the ability to walk, following treatment. While stem cell treatment remains unable to ‘cure’ COPD it is able to repair damaged tissue while staying relatively non-invasive. This attractive new treatment becomes even more desirable when you consider that current treatment protocols may require the use of ventilators, or even total lung transplants which are rare and extremely expensive.

Our two-day protocol centers on the intrathecal transplant of stem cells: a minimum of 120 million cord tissue-derived MSCs (Mesenchymal Stem Cells) are injected intravenously. The procedure takes approximately 45 minutes, is minimally invasive, and has very little downtime. Patients normally travel home two days following their scheduled appointment.


Click one of our contacts below to chat on WhatsApp